Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Viral encephalitis virus, a new bioterrorist menace].

Sophie Rigaudeau1, Romain Micol, François Bricaire

  • 1Service des maladies infectieuses et tropicales, Groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France.

Presse Medicale (Paris, France : 1983)
|February 3, 2005
PubMed
Summary

Viral encephalitis viruses pose a bioterrorist threat due to easy production and high pathogenic potential. Diagnosis is challenging, with treatment being symptomatic and supportive care crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial.

The Lancet. Oncology·2025
Same author

Improving Advanced-Line Multiple Myeloma Care: Insights and Real-World Challenges from the EMMY Study.

Clinical hematology international·2025
Same author

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study.

Haematologica·2025
Same author

mRNA vaccines: miRNA-based controlled biodistribution and directed adjuvantation.

Trends in immunology·2025
Same author

Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial.

Blood·2025
Same author

The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge.

Clinical hematology international·2024

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Context:

  • Viral encephalitis viruses present a growing concern as potential bioterrorist agents.
  • Their easy production and significant pathogenic potential exacerbate this threat.
  • Rapid diffusion can be achieved through aerosolization, posing a public health risk.

Purpose:

  • To highlight the emerging threat of viral encephalitis viruses as bioterrorist agents.
  • To discuss the diagnostic challenges and treatment strategies for viral encephalitis.
  • To underscore the potential for widespread panic and disorganization caused by such agents.

Summary:

  • Viral encephalitis viruses are increasingly recognized as bioterrorist threats due to their ease of production and virulence.

Related Experiment Videos

  • Diagnosis is often difficult, with non-specific symptoms and biological abnormalities, requiring advanced molecular techniques like PCR and RT-PCR for confirmation.
  • Treatment is primarily symptomatic, focusing on supportive care, with specific antiviral considerations like ribavirin being case-dependent and sometimes contraindicated.

    • Impact:

    • Understanding these threats is crucial for developing effective public health responses and biodefense strategies.
    • Improved diagnostic methods and targeted treatments are needed to mitigate the impact of viral encephalitis outbreaks.
    • The potential for mass panic necessitates robust security measures and clear communication protocols.